Beth Overmoyer
8PUBLICATIONS
86CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|May 16, 2025
Clinicogenomic Characterization of Inflammatory Breast Cancer.Nolan Priedigkeit, Beth Harrison, Robert Shue
|May 13, 2025
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS).Romualdo Barroso-Sousa, Jorge Gomez Tejeda Zanudo, Tianyu Li
|Mar 20, 2024
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial.Jorge Gómez Tejeda Zañudo, Romualdo Barroso-Sousa, Esha Jain
|Jun 02, 2023
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results.Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder
|Jun 02, 2023
Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer.Ana C Garrido-Castro, Meredith M Regan, Samuel M Niman
|Nov 21, 2022
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States.Laura E Stevens, Guillermo Peluffo, Xintao Qiu
Pageof 2
Frequent Collaborators
5 joint publications
Sara Tolaney
2 joint publications
Faina Nakhlis
2 joint publications
Filipa Lynce
2 joint publications
Beth T Harrison
2 joint publications
Nancy U Lin
2 joint publications
Ana Garrido-Castro
2 joint publications
Jorge Gómez Tejeda Zañudo
2 joint publications
Eric P Winer
2 joint publications
Nabihah Tayob
1 joint publications
Andrew D Cherniack
